Lithium (Li+) is the major drug presently prescribed in the treatment of manic depression. Its site of action within the central nervous system is unknown although it has been known for several years to have profound effects upon inositol (poly)phosphate metabolism. The basis of the work presented here is to investigate the effects of Li+ upon the accumulation of labelled and unlabelled inositol (poly)phosphates in muscarinic cholinergically stimulated rat cerebral cortical slices and cultured cell lines. Its effects on the accumulation of CMP-phosphatidic acid (CMP-PA), a precursor to (poly)phosphoinositide lipid resynthesis and upon the inhibition of inositol monophosphatase activity are also described. It has been shown that the presence...
Lithium, an effective treatment for mania and the preven-tion of recurrent episodes of both mania an...
The therapeutic properties of lithium ions (Li) are well known; however, the mechanism of their acti...
The ability of acute and chronic U treatment to influence agonist and depolarization-induced phOSphO...
Lithium (Li+) is the major drug presently prescribed in the treatment of manic depression. Its site ...
The work described in this thesis examines the phosphoinositide (PI) signalling system and its disru...
The effects of lithium (Li+) on the adenylyl cyclase and inositol phospholipid receptor signalling p...
Lithium is the prototype mood stabilizer but its mechanism is still unresolved. Two hypotheses domin...
The psychotherapeutic action of Li + in brain has been proposed to result from the depletion of cell...
Receptor-mediated phosphoinositide hydrolysis was studied in 3H-myo-inositol labelled rat cerebral c...
The ability of lithium to potentiate muscarinic cholinoceptor-stimulated CMP-phosphatidate (CMP.PA) ...
SummaryLithium inhibits inositol monophosphatase at therapeutically effective concentrations, and it...
The effect of lithium ion on the generation of inositol phosphates and the mobilisation of intracell...
Bipolar mood disorder (manic depression) is a major psychiatric disorder whose molecular origins are...
Inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] and inositol 1,4-bisphosphate [Ins(1,4)P2] phosphatase a...
The small ion lithium, a very effective agent in the treatment of manic depressive patients, inhibit...
Lithium, an effective treatment for mania and the preven-tion of recurrent episodes of both mania an...
The therapeutic properties of lithium ions (Li) are well known; however, the mechanism of their acti...
The ability of acute and chronic U treatment to influence agonist and depolarization-induced phOSphO...
Lithium (Li+) is the major drug presently prescribed in the treatment of manic depression. Its site ...
The work described in this thesis examines the phosphoinositide (PI) signalling system and its disru...
The effects of lithium (Li+) on the adenylyl cyclase and inositol phospholipid receptor signalling p...
Lithium is the prototype mood stabilizer but its mechanism is still unresolved. Two hypotheses domin...
The psychotherapeutic action of Li + in brain has been proposed to result from the depletion of cell...
Receptor-mediated phosphoinositide hydrolysis was studied in 3H-myo-inositol labelled rat cerebral c...
The ability of lithium to potentiate muscarinic cholinoceptor-stimulated CMP-phosphatidate (CMP.PA) ...
SummaryLithium inhibits inositol monophosphatase at therapeutically effective concentrations, and it...
The effect of lithium ion on the generation of inositol phosphates and the mobilisation of intracell...
Bipolar mood disorder (manic depression) is a major psychiatric disorder whose molecular origins are...
Inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] and inositol 1,4-bisphosphate [Ins(1,4)P2] phosphatase a...
The small ion lithium, a very effective agent in the treatment of manic depressive patients, inhibit...
Lithium, an effective treatment for mania and the preven-tion of recurrent episodes of both mania an...
The therapeutic properties of lithium ions (Li) are well known; however, the mechanism of their acti...
The ability of acute and chronic U treatment to influence agonist and depolarization-induced phOSphO...